Sameer Thapar PharmD

Dr. Thapar has extensive experience in operations within the pharmaceutical, biotech and CRO industries, with cross-functional experience in medical, clinical and quality, and subject matter expertise in pharmacovigilance operations and compliance. He has built global departments and run lean organizations while improving efficiencies. He is well-versed in numerous therapeutic areas and databases. Dr. Thapar is chief principal in MedEsq LLC, a pharmacovigilance and risk management consulting firm, and is on faculty as a professor for the drug safety and pharmacovigilance track of the Masters in Clinical Trial Sciences program at Rutgers University.